Active Symptom Monitoring in Patients Undergoing Radiation Therapy for Thoracic Malignancies

Washington University School of Medicine1 site in 1 country36 target enrollmentSeptember 3, 2020

Overview

Phase: N/A
Intervention: Not specified
Conditions: Symptom Monitoring
Sponsor: Washington University School of Medicine
Enrollment: 36
Locations: 1
Primary Endpoint: Percentage of invited symptom reports completed during the study period
Status: Completed
Last Updated: 4 years ago

This study seeks to achieve two aims:

To assess the implementation of Noona software for continuous symptom monitoring for a diverse population of patients with thoracic malignancies who are undergoing radiation and
To validate remote collection of standardized PRO measures using Noona software.

Registry

clinicaltrials.gov

Start Date

September 3, 2020

End Date

March 13, 2022

Last Updated

4 years ago

Study Type

Observational

Sex

All

Sponsor

Responsible Party

Sponsor

•Biopsy confirmed cancer. Radiographically apparent (i.e. not histologically or cytologically confirmed) malignancy of the thorax is allowed.
•Currently planning to receive radiotherapy with or without chemotherapy for greater than one fraction.
•Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).
•Age 18 years or older

Percentage of invited symptom reports completed during the study period

Time Frame: Treatment through 90 days of follow-up (estimated to be 5 months)

Percentage of questions completed within each invited symptom report

Time Frame: Treatment through 90 days of follow-up (estimated to be 5 months)

Patient reported outcomes as measured by EORTC QLQ-C30(Baseline, within 1 week of completing therapy and at 90-day follow-up)
Patient reported outcomes as measured by NCCN Distress Thermometer(Baseline, within 1 week of completing therapy and at 90-day follow-up)